Hepion Pharmaceuticals Inc
PublicHepion Pharmaceuticals Inc is now publicly traded
The data on this page reflects Hepion Pharmaceuticals Inc's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Follow-on Offering
Apr 22, 2026
Total Funding Raised
$700,000
Company Overview
Hepion Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that focuses on the development of drug therapies for the treatment of chronic liver diseases.
Sector
Healthcare
AI Layer
Application
Keywords
Hepion Pharmaceuticals Inc Comparables
Compare Hepion Pharmaceuticals Inc with similar companies based on industry and business-model similarity.
No public comparables are available for Hepion Pharmaceuticals Inc. Request access to learn about comparables coverage.
Request accessHepion Pharmaceuticals Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Apr 22, 2026 |
Hepion Pharmaceuticals Inc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access